title: Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.
abstract: Recombinant human adenovirus serotype 5 (HAd5V) vectors are gold standards of T-cell immunogenicity as they efficiently induce also humoral responses to exogenous antigens, in particular when used in prime-boost protocols. Some investigators have shown that pre-existing immunity to adenoviruses interferes with transduction by adenoviral vectors, but the actual extent of this interference is not known since it has been mostly studied in mice using unnatural routes of infection and virus doses. Here we studied the effects of HAd5V-specific immune responses induced by intranasal infection on the transduction efficiency of recombinant adenovirus vectors. Of interest, when HAd5V immunity was induced in mice by the natural respiratory route, the pre-existing immunity against HAd5V did not significantly interfere with the B and T-cell immune responses against the transgene products induced after a prime/boost inoculation protocol with a recombinant HAd5V-vector, as measured by ELISA and in vivo cytotoxic T-cell assays, respectively. We also correlated the levels of HAd5V-specific neutralizing antibodies (Ad5NAbs) induced in mice with the levels of Ad5NAb titers found in humans. The data indicate that approximately 60% of the human serum samples tested displayed Ad5NAb levels that could be overcome with a prime-boost vaccination protocol. These results suggest that recombinant HAd5V vectors are potentially useful for prime-boost vaccination strategies, at least when pre-existing immunity against HAd5V is at low or medium levels.
authors.affiliation: Department of Microbiology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
authors.forename: Bruna
authors.initials: B
authors.lastname: de Andrade Pereira
authors.affiliation: Department of Microbiology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
authors.forename: Leoneide E
authors.initials: LE
authors.lastname: Maduro Bouillet
authors.affiliation: Department of Microbiology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
authors.forename: Natalia A
authors.initials: NA
authors.lastname: Dorigo
authors.affiliation: Institute of Virology, University of Zürich, Zürich, Switzerland.
authors.forename: Cornel
authors.initials: C
authors.lastname: Fraefel
authors.affiliation: Department of Microbiology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
authors.forename: Oscar
authors.initials: O
authors.lastname: Bruna-Romero
mesh_terms: D000258:Adenovirus Infections, Human / Q000276:immunology* / Q000635:transmission; D062705:Adenovirus Vaccines / Q000008:administration & dosage / Q000276:immunology*; D000818:Animals; D057134:Antibodies, Neutralizing / Q000276:immunology; D000914:Antibodies, Viral / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D013601:T-Lymphocytes / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D062705:Adenovirus Vaccines; D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D014614:Vaccines, Synthetic